Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases

Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases

ᅟ

Bibliographic Details
Main Authors: Wan-Ling Tan, Quan Sing Ng, Cindy Lim, Eng Huat Tan, Chee Keong Toh, Mei-Kim Ang, Ravindran Kanesvaran, Amit Jain, Daniel S. W. Tan, Darren Wan-Teck Lim
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Cancer
Online Access:http://link.springer.com/article/10.1186/s12885-018-5215-7

Internet

http://link.springer.com/article/10.1186/s12885-018-5215-7

Similar Items